Juan's Systems Biology Laboratory
From proteins to proteomics and beyond.... Aimed for drug discovery and bioenergy development; Systems & synthetic biology research
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
publication:juan [2019/10/02 04:26] 游文萱 |
publication:juan [2019/10/02 04:28] 游文萱 |
||
|---|---|---|---|
| Line 2: | Line 2: | ||
| ===== Journal Papers / 期刊論文 ===== | ===== Journal Papers / 期刊論文 ===== | ||
| - | - Cheung, H. Y. C., Hsu, C.-L., Tsuei, C.-Y., Kuo, T.-T., Huang, C.-T., Hsu, W.-M., Chung, Y.-H., Wu, H.-Y., Hsu, C.-C., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy" //Cell Death and Disease// (Accepted) | + | - Cheung, H. Y. C., Hsu, C.-L., Tsuei, C.-Y., Kuo, T.-T., Huang, C.-T., Hsu, W.-M., Chung, Y.-H., Wu, H.-Y., Hsu, C.-C., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy" //Cell Death and Disease// (Accepted). |
| - | - Hsieh, C.-H., Cheung, C. H. Y., Liu, Y.-L., Hou, C.-L., Hsu, C.-L., Huang, C.-T., Yang, T.-S., Chen, S.-F., Chen, C.-N., Hsu, W.-M.*, Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Quantitative proteomics of Th-MYCN transgenic mice reveals aurora kinase inhibitor altered metabolic pathways and enhanced ACADM to suppress neuroblastoma progression" //Journal of Proteome Research// (Accepted) | + | - Hsieh, C.-H., Cheung, C. H. Y., Liu, Y.-L., Hou, C.-L., Hsu, C.-L., Huang, C.-T., Yang, T.-S., Chen, S.-F., Chen, C.-N., Hsu, W.-M.*, Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Quantitative proteomics of Th-MYCN transgenic mice reveals aurora kinase inhibitor altered metabolic pathways and enhanced ACADM to suppress neuroblastoma progression" //Journal of Proteome Research// (Accepted). |
| - Chang, H.-C., Huang, H.-C., __**Juan, H.-F.**__*, Hsu, C.-L* (2019) "Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation" //BMC Genomics// (Accepted). | - Chang, H.-C., Huang, H.-C., __**Juan, H.-F.**__*, Hsu, C.-L* (2019) "Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation" //BMC Genomics// (Accepted). | ||
| - | - Wu, P.-Y., Yu, I-S., Lin, Y.-C., Chang, Y.-T., Chen, C.-C., Lin, K.-H., Tseng, T.-H., Kargren, M., Tai, Y.-L., Shen, T.-L., Liu, Y.-L., Wang, B.-J., Chang, C.-H., Chen, W.-M., __Juan, H.-F.__, Huang, S.-F., Chan, Y.-Y., Liao, Y.-F., Hsu, W.-M., Lee, H. (2019) "Activation of aryl hydrocarbon receptor by kynurenine impairs progression and metastasis of neuroblastoma" //Cancer Research// (in press). | + | - Wu, P.-Y., Yu, I-S., Lin, Y.-C., Chang, Y.-T., Chen, C.-C., Lin, K.-H., Tseng, T.-H., Kargren, M., Tai, Y.-L., Shen, T.-L., Liu, Y.-L., Wang, B.-J., Chang, C.-H., Chen, W.-M., __**Juan, H.-F.**__, Huang, S.-F., Chan, Y.-Y., Liao, Y.-F., Hsu, W.-M., Lee, H. (2019) "Activation of aryl hydrocarbon receptor by kynurenine impairs progression and metastasis of neuroblastoma" //Cancer Research// (in press). |
| - Huang, C.-T., Hsieh, C.-H., Lee, W.-C., Liu, Y.-L., Yang, T.-S., Hsu, W.-M., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Therapeutic targeting of non-oncogene dependencies in high-risk neuroblastoma" //Clinical Cancer Research// 25(13):4063-4078. | - Huang, C.-T., Hsieh, C.-H., Lee, W.-C., Liu, Y.-L., Yang, T.-S., Hsu, W.-M., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Therapeutic targeting of non-oncogene dependencies in high-risk neuroblastoma" //Clinical Cancer Research// 25(13):4063-4078. | ||
| - Huang, C.-T., Hsieh, C.-H., Chung, Y.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Perturbational gene-expression signatures for combinatorial drug discovery" //iScience// 15:291-306 (**Cell Press**). | - Huang, C.-T., Hsieh, C.-H., Chung, Y.-H., Oyang, Y.-J., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Perturbational gene-expression signatures for combinatorial drug discovery" //iScience// 15:291-306 (**Cell Press**). | ||